Skip to content

T Wave Alternans in Hemodialysis

Pilot Study of a Noninvasive Predictor of Sudden Cardiac Death in Hemodialysis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00296543
Enrollment
30
Registered
2006-02-27
Start date
2005-10-31
Completion date
2008-08-31
Last updated
2011-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure, Coronary Heart Disease, End Stage Renal Disease

Keywords

hemodialysis, sudden cardiac death

Brief summary

The purpose of this study is to determine if the hemodialysis procedure changes the risk for cardiac arrest in patients.

Detailed description

One-third to one-quarter of hemodialysis patients die of sudden cardiac death (SCD). The hemodialysis procedure may theoretically increase the risk of SCD. This study uses T wave alternans, a noninvasive marker of SCD, to objectively determine whether the hemodialysis procedure alters the risk of SCD in hemodialysis patients.

Interventions

None listed

Sponsors

Dialysis Clinic, Inc.
CollaboratorINDUSTRY
Indiana University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Normal sinus rhythm

Exclusion criteria

* Inability to give written informed consent * Active cardiac ischemia * Pacemaker * Inability to perform a brief walking treadmill test

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026